E-LIB Suche - Ergebnisse für: Giroux, B

1

HEREDITARY NEUROPATHIES & ALS:

Elouej, S. ; Delamare, M. ; Cappella, M....
Neuromuscular Disorders. 30 (2020) - p. S80 , 2020

Link: https://doi.org/10.1016/..

2

P.91Optimization of AAV-mediated gene therapy for SOD1-link..:

Biferi, M. ; Cohen-Tannoudji, M. ; Marais, T...
Neuromuscular Disorders. 29 (2019) - p. S67 , 2019

Link: https://doi.org/10.1016/..

3

A new AAV10-mediated gene therapy for SOD1 -linked ALS:

Biferi, M. ; Cohen-Tannoudji, M. ; Cappelletto, A....
Neuromuscular Disorders. 27 (2017) - p. S246 , 2017

Link: https://doi.org/10.1016/..

4

Phase I and pharmacokinetic study of capecitabine and cispl..:

Pivot, X. ; Chamorey, E. ; Guardiola, E....
European Journal of Cancer. 37 (2001) - p. S73-S74 , 2001

Link: https://doi.org/10.1016/..

5

Time-schedule dependency of S 16020, a new topoisomerase II..:

Soudon, J ; Milano, G ; Poullain, M G...
Anti-Cancer Drugs. 10 (1999) 6 - p. 597-604 , 1999

Link: https://doi.org/10.1097/..

6

Phase I trial and pharmacokinetic (PK) study of S16020 acco..:

Brian, E. ; Di Palma, M. ; Etassami, A....
European Journal of Cancer. 35 (1999) - p. S288-S289 , 1999

Link: https://doi.org/10.1016/..

7

Phase I pharmacological study of intra-arterially infused f..:

Hartmann, J.T ; Schmoll, E ; Bokemeyer, C...
European Journal of Cancer. 34 (1998) 1 - p. 87-91 , 1998

Link: https://doi.org/10.1016/..

8

Hypothyroïdie centrale hypophysaire par déficit isolé en TS..:

Giroux, B ; Metz, C ; Giroux, JD.
Archives de Pédiatrie. 4 (1997) 11 - p. 1146-1148 , 1997

Link: https://doi.org/10.1016/..

9

Hypothyroïdie centrale de découverte néonatale:

Giroux, B ; Metz, C ; Giroux, J.D.
Archives de Pédiatrie. 4 (1997) 6 - p. 542-546 , 1997

Link: https://doi.org/10.1016/..

10

5 In vitro studies of S9788 as a reversing agent of P-glyco..:

Fenart, L. ; Poullain, M. G. ; Giroux, B...
Cell Biology and Toxicology. 12 (1996) 4-6 - p. 369-369 , 1996

Link: https://doi.org/10.1007/..

11

A phase II trial of fotemustine and cisplatin in central ne..:

Cotto, C. ; Berille, J. ; Souquet, P.J....
European Journal of Cancer. 32 (1996) 1 - p. 69-71 , 1996

Link: https://doi.org/10.1016/..

12

273 Pretreatment with procarbazine does not circumvent the ..:

Rodier, J.M. ; Da Costa, L. ; Trandafir, L....
European Journal of Cancer. 31 (1995) - p. S60 , 1995

Link: https://doi.org/10.1016/..

13

Fotemustine, dacarbazine, vindesine combination chemotherap..:

Rixe, O ; Borel, C. ; Paraiso, D....
Melanoma Research. 5 (1995) 6 - p. 419-424 , 1995

Link: https://doi.org/10.1097/..

14

15 An update of chemotherapy including fotemustine in the t..:

Khayat, D. ; Borel, C. ; Breitbart, E....
Melanoma Research. 5 (1995) 6 - p. 447 , 1995

Link: https://doi.org/10.1097/..

15

Tumor exposure to fotemustine in malignant gliomas. The hig..:

Frenay, M. ; Biron, P. ; Poisson, M..
European Journal of Cancer. 29 (1993) - p. S189 , 1993

Link: https://doi.org/10.1016/..